Adaptimmune Therapeutics PLC (ADAPY) Gross Profit (2025)
Adaptimmune Therapeutics (ADAPY) reported Gross Profit of $11.18 million for Q2 2025, up 74.5% from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) Gross Profit (2025) Analysis & Trends
For FY2024, Adaptimmune Therapeutics posted Gross Profit of $177.96 million.
Peer Set
Peer Comparison
API Access
Adaptimmune Therapeutics PLC Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();